Ghazali Naseem, Roe Brenda, Lowe Derek, Tandon Sank, Jones Terry, Brown James, Shaw Richard, Risk Janet, Rogers Simon N
Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Regional Maxillofacial Unit, Aintree University Hospitals NHS Trust, Lower Lane, Liverpool, L9 7AL, UK.
Eur Arch Otorhinolaryngol. 2017 May;274(5):2253-2260. doi: 10.1007/s00405-017-4474-2. Epub 2017 Feb 6.
The primary aim was to determine the efficacy of the Distress Thermometer (DT) in screening for anxiety and mood problems against the University of Washington Quality of Life, version 4 (UWQOL). Secondary aims were to evaluate the association between demographic, clinical and health-related QOL variables with significant distress. Two hundred and sixty one disease-free HNC ambulatory patients attending routine follow-up clinics were prospectively recruited. Both DT and UWQOL were completed pre-consultation. Receiver operating characteristic (ROC) curve analyses of DT score for anxiety dysfunction yielded an area under the curve (AUC) of 0.877, with a sensitivity of 84% (43/51) and specificity of 76% (159/210) for a DT cut-off of ≥4; with a corresponding AUC of 0.825 for mood with sensitivity 78% (28/36) and specificity 71% (159/225). Treatment with radiotherapy and a longer consultation time were associated with significant distress (DT ≥4). Significant distress was also reported in two third of those reporting less than "Good" overall QOL. Distress levels were particularly associated with poor Social-Emotional function, more so than the association seen with poor physical function. DT is a reasonable screening tool for distress in the HNC population. The DT cut-off score ≥4 was effective in identifying those with significant distress. Significant distress is associated in survivors with poor health-related quality of life, those who received radiotherapy and patients who have longer consultation times in clinic.
主要目的是确定痛苦温度计(DT)相对于华盛顿大学生活质量问卷第4版(UWQOL)在筛查焦虑和情绪问题方面的有效性。次要目的是评估人口统计学、临床和与健康相关的生活质量变量与显著痛苦之间的关联。前瞻性招募了261名在常规随访诊所就诊的无病头颈癌门诊患者。DT和UWQOL均在咨询前完成。对焦虑功能障碍的DT评分进行受试者操作特征(ROC)曲线分析,曲线下面积(AUC)为0.877,DT临界值≥4时,敏感性为84%(43/51),特异性为76%(159/210);情绪方面相应的AUC为0.825,敏感性为78%(28/36),特异性为71%(159/225)。放疗治疗和较长的咨询时间与显著痛苦(DT≥4)相关。在总体生活质量报告低于“良好”的患者中,也有三分之二报告有显著痛苦。痛苦水平与社会情感功能差尤其相关,比与身体功能差的关联更明显。DT是头颈癌人群中一种合理的痛苦筛查工具。DT临界值≥4可有效识别有显著痛苦的患者。显著痛苦与健康相关生活质量差的幸存者、接受放疗的患者以及在诊所咨询时间较长的患者相关。